Nick Leschly
Président chez 2SEVENTY BIO, INC.
Fortune : 6 M $ au 30/06/2024
Profil
Nick Leschly a fondé Medxtend Corp. Actuellement, il occupe le poste de président, directeur général et directeur de bluebird bio, Inc. et directeur général de FierceBiotech. Il est également membre du conseil d'administration de Biotechnology Innovation Organization, Synlogic Operating Co., Inc. et Synlogic, Inc. Dans sa carrière antérieure, il a été directeur général de Medxtend Corp, directeur commercial d'Agios Pharmaceuticals, Inc. et associé de Third Rock Ventures LLC. Nick Leschly a obtenu un diplôme de premier cycle à l'université de Princeton et un MBA à la Wharton School de l'université de Pennsylvanie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
2SEVENTY BIO, INC.
2,68% | 08/01/2024 | 1 376 709 ( 2,68% ) | 5 M $ | 30/06/2024 |
BLUEBIRD BIO, INC.
0,24% | 16/06/2023 | 459 638 ( 0,24% ) | 452 284 $ | 30/06/2024 |
SYNLOGIC INC
0,01% | 31/03/2024 | 1 543 ( 0,01% ) | 2 315 $ | 30/06/2024 |
Postes actifs de Nick Leschly
| Sociétés | Poste | Début |
|---|---|---|
| BLUEBIRD BIO, INC. | Directeur/Membre du Conseil | 01/09/2010 |
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 28/08/2017 |
| 2SEVENTY BIO, INC. | Président | 01/04/2024 |
FierceBiotech
 FierceBiotech Commercial Printing/FormsCommercial Services FierceBiotech is an American company that publishes magazines and articles. The private company is based in Washington. The CEO of the company is Nick Leschly. | Directeur Général | 21/04/2011 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 23/03/2016 |
| Synlogic Therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Nick Leschly
| Sociétés | Poste | Fin |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 30/06/2009 |
| Medxtend Corp. | Directeur Général | 01/03/2001 |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Nick Leschly
| Princeton University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
FierceBiotech
FierceBiotech Commercial Printing/FormsCommercial Services FierceBiotech is an American company that publishes magazines and articles. The private company is based in Washington. The CEO of the company is Nick Leschly. | Commercial Services |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
| Medxtend Corp. | |
| Synlogic Therapeutics | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
